Ashland Posts Earnings Gain, Beats Estimates

Ashland reported preliminary net earnings of $93 million in its fiscal fourth quarter ended September 30, compared with a net loss of $10 million in the same period last year. On an adjusted, pro-forma basis, which includes Hercules’ results in each period, sales fell 25%, to $2.1 billion, and Ebitda rose 37%, to $224 million. Earnings of $1.22/share beat the consensus of analysts’ estimates of 90 cts/share, as reported by Thomson Reuters (New York). Adjusted, pro-forma Ebitda in Ashland Aqualon Functional Ingredients fell 16%, to $56 million. The...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers